SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Grauslund, J., Abou Taha, A., Dehghani Molander, L., Kawasaki, R., Mller, S., Hjlund, K., & Stokholm, L., Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes, International Journal of Retina and Vitreous , accepted for publication
Is oral GLP-1 as effective as injectable therapy
Di Cristo F, Calarco A, Digilio FA, Sinicropi MS, Rosano C, Galderisi U, Melone MAB, Saturnino C, Peluso G (2020) The discovery of highly potent THP derivatives as OCTN2 inhibitors: from structure-based virtual screening to in vivo biological activity
Possession for research purposes may be permitted under specific conditions, but injecting unapproved peptides carries legal and health risks
Yes, glutathione can be safely combined with other supplements or topical agents, but it is advisable to consult with a healthcare provider to ensure compatibility